Ekholm E - Search Results

1

The poorly explored impact of uncontrolled asthma.

O'Byrne PM, Pedersen S, Schatz M, Thoren A, Ekholm E, Carlsson LG, Busse WW. O'Byrne PM, et al. Among authors: ekholm e. Chest. 2013 Feb 1;143(2):511-523. doi: 10.1378/chest.12-0412. Chest. 2013. PMID: 23381316 Review.

2

Safety, Pharmacokinetics and Pharmacodynamics of the Selective Glucocorticoid Receptor Modulator AZD5423 after Inhalation in Healthy Volunteers.

Werkström V, Prothon S, Ekholm E, Jorup C, Edsbäcker S. Werkström V, et al. Among authors: ekholm e. Basic Clin Pharmacol Toxicol. 2016 Dec;119(6):574-581. doi: 10.1111/bcpt.12621. Epub 2016 Jul 8. Basic Clin Pharmacol Toxicol. 2016. PMID: 27214145 Free article. Clinical Trial.

3

Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.

Araki E, Onishi Y, Asano M, Kim H, Ekholm E, Johnsson E, Yajima T. Araki E, et al. Among authors: ekholm e. J Diabetes Investig. 2016 Jul;7(4):555-64. doi: 10.1111/jdi.12453. Epub 2016 Jan 22. J Diabetes Investig. 2016. PMID: 27181422 Free PMC article. Clinical Trial.

4

Model-based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus.

Parkinson J, Tang W, Åstrand M, Melin J, Ekholm E, Hamrén B, Boulton DW. Parkinson J, et al. Among authors: ekholm e. Diabetes Obes Metab. 2019 Jun;21(6):1381-1387. doi: 10.1111/dom.13664. Epub 2019 Mar 14. Diabetes Obes Metab. 2019. PMID: 30756462 Free PMC article. Clinical Trial.

5

Dapagliflozin Plus Saxagliptin Add-on Therapy Compared With Insulin in Patients With Type 2 Diabetes Poorly Controlled by Metformin With or Without Sulfonylurea Therapy: A Randomized Clinical Trial.

Vilsbøll T, Ekholm E, Johnsson E, Dronamraju N, Jabbour S, Lind M. Vilsbøll T, et al. Among authors: ekholm e. Diabetes Care. 2019 Aug;42(8):1464-1472. doi: 10.2337/dc18-1988. Epub 2019 Jun 4. Diabetes Care. 2019. PMID: 31167892 Clinical Trial.

6

Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.

Vilsbøll T, Ekholm E, Johnsson E, Garcia-Sanchez R, Dronamraju N, Jabbour SA, Lind M. Vilsbøll T, et al. Among authors: ekholm e. Diabetes Obes Metab. 2020 Jun;22(6):957-968. doi: 10.1111/dom.13981. Epub 2020 Feb 23. Diabetes Obes Metab. 2020. PMID: 32003150 Free PMC article. Clinical Trial.

7

COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION.

Ekholm E, Hansen L, Johnsson E, Iqbal N, Carlsson B, Chen H, Hirshberg B. Ekholm E, et al. Endocr Pract. 2017 Mar;23(3):258-265. doi: 10.4158/EP161323.OR. Epub 2016 Nov 16. Endocr Pract. 2017. PMID: 27849380 Clinical Trial.

8

Randomized, Double-Blind Trial of Triple Therapy With Saxagliptin Add-on to Dapagliflozin Plus Metformin in Patients With Type 2 Diabetes.

Matthaei S, Catrinoiu D, Celiński A, Ekholm E, Cook W, Hirshberg B, Chen H, Iqbal N, Hansen L. Matthaei S, et al. Among authors: ekholm e. Diabetes Care. 2015 Nov;38(11):2018-24. doi: 10.2337/dc15-0811. Epub 2015 Aug 31. Diabetes Care. 2015. PMID: 26324329 Clinical Trial.

9

Randomized, Double-Blind, Phase 3 Trial of Triple Therapy With Dapagliflozin Add-on to Saxagliptin Plus Metformin in Type 2 Diabetes.

Mathieu C, Ranetti AE, Li D, Ekholm E, Cook W, Hirshberg B, Chen H, Hansen L, Iqbal N. Mathieu C, et al. Among authors: ekholm e. Diabetes Care. 2015 Nov;38(11):2009-17. doi: 10.2337/dc15-0779. Epub 2015 Aug 5. Diabetes Care. 2015. PMID: 26246458 Clinical Trial.

10

Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapy.

Hansen L, Iqbal N, Ekholm E, Cook W, Hirshberg B. Hansen L, et al. Among authors: ekholm e. Endocr Pract. 2014 Nov;20(11):1187-97. doi: 10.4158/EP14489.OR. Endocr Pract. 2014. PMID: 25370334

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

171 results

Search Page